These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8559041)
1. Persistent Yersinia enterocolitica infection in three rat strains. Curfs JH; Meis JF; Van der Lee HA; Mulder JA; Kraak WA; Hoogkamp-Korstanje JA Microb Pathog; 1995 Jul; 19(1):57-63. PubMed ID: 8559041 [TBL] [Abstract][Full Text] [Related]
2. Local expression of cytokine mRNA in spleen and Peyer's patches of rats is involved in resistance against infection with Yersinia enterocolitica. Odinot PT; Curfs JH; Meis JF; Melchers WJ; Hoogkamp-Korstanje JA Cytokine; 1998 Mar; 10(3):206-12. PubMed ID: 9576066 [TBL] [Abstract][Full Text] [Related]
3. Experimental Yersinia enterocolitica infection in rats: analysis of the immune response to plasmid-encoded antigens of arthritis-susceptible Lewis rats and arthritis-resistant Fischer rats. Gaede K; Mack D; Heesemann J Med Microbiol Immunol; 1992; 181(3):165-72. PubMed ID: 1522826 [TBL] [Abstract][Full Text] [Related]
4. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. Heesemann J; Gaede K; Autenrieth IB APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822 [TBL] [Abstract][Full Text] [Related]
5. Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats. Gaede KI; Heesemann J Infect Immun; 1995 Feb; 63(2):714-9. PubMed ID: 7822048 [TBL] [Abstract][Full Text] [Related]
6. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Hill JL; Yu DT Infect Immun; 1987 Mar; 55(3):721-6. PubMed ID: 3493220 [TBL] [Abstract][Full Text] [Related]
7. Humoral immune response in Yersinia enterocolitica O:5 induced arthritis in hamsters. Di Genaro MS; Escudero ME; Velázquez LC; Muñoz E; Aguilera C; Juárez A; Scardapane L; Stefanini de Guzmán AM Microbiol Immunol; 1997; 41(8):615-20. PubMed ID: 9310941 [TBL] [Abstract][Full Text] [Related]
8. Relation of YadA to arthritogenicity of Yersinia enterocolitica: experimental studies in the rat. Gripenberg-Lerche C; Skurnik M; Toivanen P Contrib Microbiol Immunol; 1995; 13():188-90. PubMed ID: 8833830 [No Abstract] [Full Text] [Related]
9. Role of YadA-mediated collagen binding in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Gripenberg-Lerche C; Skurnik M; Toivanen P Infect Immun; 1995 Aug; 63(8):3222-6. PubMed ID: 7622253 [TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Hoogkamp-Korstanje JA; Moesker H; Bruyn GA Ann Rheum Dis; 2000 Nov; 59(11):914-7. PubMed ID: 11053072 [TBL] [Abstract][Full Text] [Related]
11. Treatment of arthritis in Lewis rats by a monoclonal antibody against alpha beta T cell receptor: differential sensitivity of Yersinia-induced arthritis versus adjuvant arthritis. Gaede K; Nazet M; Bosse D; Hünig ; Heesemann J Clin Immunol Immunopathol; 1995 Dec; 77(3):339-48. PubMed ID: 7586745 [TBL] [Abstract][Full Text] [Related]
12. Yersinia-associated arthritis in the rat: experimental model for human reactive arthritis? Toivanen A; Merilahti-Palo R; Gripenberg C; Lahesmaa-Rantala R; Söderström KO; Jaakkola UM Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):261-9. PubMed ID: 3495095 [TBL] [Abstract][Full Text] [Related]
13. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Granfors K; Merilahti-Palo R; Luukkainen R; Möttönen T; Lahesmaa R; Probst P; Märker-Hermann E; Toivanen P Arthritis Rheum; 1998 May; 41(5):855-62. PubMed ID: 9588737 [TBL] [Abstract][Full Text] [Related]
14. Invasion and dissemination of Yersinia enterocolitica in the mouse infection model. Trülzsch K; Oellerich MF; Heesemann J Adv Exp Med Biol; 2007; 603():279-85. PubMed ID: 17966424 [TBL] [Abstract][Full Text] [Related]
15. Yersinia enterocolitica O:3 isolated from patients with or without reactive arthritis induces polyclonal activation of B cells and autoantibody production in vivo. Silva EE; Ramos OP; Bauab TM; Falcão DP; de Medeiros BM Autoimmunity; 2003 Aug; 36(5):261-8. PubMed ID: 14567555 [TBL] [Abstract][Full Text] [Related]
16. An experimental mouse model of Yersinia-induced reactive arthritis. Yong Z; Hill JL; Hirofuji T; Mander M; Yu DT Microb Pathog; 1988 Apr; 4(4):305-10. PubMed ID: 3200165 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Zhang Y; Gripenberg-Lerche C; Söderström KO; Toivanen A; Toivanen P Arthritis Rheum; 1996 Jul; 39(7):1238-43. PubMed ID: 8670337 [TBL] [Abstract][Full Text] [Related]
18. Yersinia enterocolitica serotype O:3 is arthritogenic for mice. de los Toyos JR; Vázquez J; Sampedro A; Hardisson C Microb Pathog; 1990 May; 8(5):363-70. PubMed ID: 2215184 [TBL] [Abstract][Full Text] [Related]
19. Yersinia associated arthritis in SHR rats: effect of the microbial status of the host. Gripenberg-Lerche C; Toivanen P Ann Rheum Dis; 1993 Mar; 52(3):223-8. PubMed ID: 8484677 [TBL] [Abstract][Full Text] [Related]
20. Immunoblot analysis of antibody response to Yersinia enterocolitica in patients with reactive arthritis and enterocolitis. Kihlström E; Frydén A; Grönberg A Contrib Microbiol Immunol; 1991; 12():93-7. PubMed ID: 1935120 [No Abstract] [Full Text] [Related] [Next] [New Search]